Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:794-801

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campos, H.
Right arrow Articles by Krauss, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campos, H.
Right arrow Articles by Krauss, R. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:794-801.)
© 1996 American Heart Association, Inc.


Articles

Differences in Receptor Binding of LDL Subfractions

Hannia Campos; Kay S. Arnold; Maureen E. Balestra; Thomas L. Innerarity; Ronald M. Krauss

From the Donner Laboratory, University of California, and the Department of Molecular and Nuclear Medicine, Life Sciences Division, Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley (H.C., R.M.K.), and the Gladstone Institute of Cardiovascular Disease, San Francisco (K.S.A., M.E.B., T.L.I.), California.

Correspondence to Ronald M. Krauss, MD, Ernest Orlando Lawrence Berkeley National Laboratory, University of California, Donner Laboratory Room 465, One Cyclotron Rd, Berkeley, CA 94720. E-mail rmkrauss@lbl.gov.

Abstract Differences in low density lipoprotein (LDL) receptor-binding affinity among LDL particles of different size were examined in competitive binding assays in human skin fibroblasts and LDL (d=1.020 to 1.050 g/mL) from subjects with a predominance of large (>=272 Å), medium (259 to 271 Å), and small (<=257 Å) LDL. Among 57 normolipidemic subjects with LDL cholesterol (-C) levels <160 mg/dL, binding affinity was reduced by 16% in those with predominantly large LDL and by 14% in those with small LDL compared with most subjects who had a predominance of medium-size LDL and in all LDL size subgroups in 66 subjects with LDL-C >=160 mg/dL. Differences in LDL receptor-binding affinity were further investigated by using LDL density subfractions (I, d=1.026 to 1.032 g/mL; II, d=1.032 to 1.038 g/mL; and III, d=1.038 to 1.050 g/mL) from three subjects with predominantly large (pattern A) and small (pattern B) LDL particles. The binding affinity (Kd) of LDL-II was similar for patterns A and B (9.2±1.4 and 9.4±0.7, respectively) and 30% lower in LDL-III from both groups (P<.05). The binding affinity of LDL-I in pattern A (12.6±1.5 µg/mg) was lower (P<.05) than that in LDL-II and LDL-I from pattern B (8.0±2.4 µg/mg). After incubation with a monoclonal antibody that specifically blocked the LDL receptor-binding domain of apoE, LDL-I from two pattern B subjects showed substantially lower binding affinity (Kd=20.0 and 19.2 µg/mg) than in pattern A (Kd=13.2 and 14.2 µg/mg), a result consistent with our finding of a higher apoE content in pattern B LDL-I (P<.001). Thus, factors associated with variations in particle size and apoE content in LDL subclasses in normolipidemic subjects contribute to the differences in LDL receptor binding that may result in differing metabolic behavior in vivo.


Key Words: LDL subclasses • LDL size • apoE • LDL receptor • cholesterol




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. B. van Schalkwijk, A. A. de Graaf, B. van Ommen, K. van Bochove, P. C. N. Rensen, L. M. Havekes, N. C. A. van de Pas, H. C. J. Hoefsloot, J. van der Greef, and A. P. Freidig
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size
J. Lipid Res., December 1, 2009; 50(12): 2398 - 2411.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Mora
Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
Circulation, May 5, 2009; 119(17): 2396 - 2404.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Qiu and J. S. Hill
Endothelial lipase enhances low density lipoprotein binding and cell association in THP-1 macrophages
Cardiovasc Res, December 1, 2007; 76(3): 528 - 538.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. C. Rambaldi, A. Zattoni, S. Casolari, P. Reschiglian, D. Roessner, and C. Johann
An analytical method for size and shape characterization of blood lipoproteins.
Clin. Chem., November 1, 2007; 53(11): 2026 - 2029.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. L. Rufail, H. A. Schenkein, S. E. Barbour, J. G. Tew, and R. van Antwerpen
Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
J. Lipid Res., December 1, 2005; 46(12): 2752 - 2760.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. M. Krauss
Dietary and Genetic Probes of Atherogenic Dyslipidemia
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2265 - 2272.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Stan, E. Levy, E. E. Delvin, J. A. Hanley, B. Lamarche, J. O'Loughlin, G. Paradis, and M. Lambert
Distribution of LDL Particle Size in a Population-Based Sample of Children and Adolescents and Relationship with Other Cardiovascular Risk Factors
Clin. Chem., July 1, 2005; 51(7): 1192 - 1200.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Bosse, L. Perusse, and M.-C. Vohl
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. M. Krauss
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Diabetes Care, June 1, 2004; 27(6): 1496 - 1504.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Charest, S. Desroches, C. A. Vanstone, P. J. H. Jones, and B. Lamarche
Unesterified Plant Sterols and Stanols Do Not Affect LDL Electrophoretic Characteristics in Hypercholesterolemic Subjects
J. Nutr., March 1, 2004; 134(3): 592 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. K. Berneis and R. M. Krauss
Metabolic origins and clinical significance of LDL heterogeneity
J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. M. Krauss, H. Campos, and F. M. Sacks
Is the Size of Low-Density Lipoprotein Particles Related to the Risk of Coronary Heart Disease?
JAMA, February 13, 2002; 287(6): 712 - 713.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. P. Segrest, M. K. Jones, H. De Loof, and N. Dashti
Structure of apolipoprotein B-100 in low density lipoproteins
J. Lipid Res., September 1, 2001; 42(9): 1346 - 1367.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. L. Bakker, J. C. ter Maaten, C. Popp-Snijders, J. P. J. Slaets, R. J. Heine, and R. O. B. Gans
The Relationship between Thyrotropin and Low Density Lipoprotein Cholesterol Is Modified by Insulin Sensitivity in Healthy Euthyroid Subjects
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1206 - 1211.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
R. M. Krauss
Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions
J. Nutr., February 1, 2001; 131(2): 340S - 343.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
A. Pedersen, M. W. Baumstark, P. Marckmann, H. Gylling, and B. Sandström
An olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets
J. Lipid Res., December 1, 2000; 41(12): 1901 - 1911.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Wang, R. Pease, J. Bertinato, and R. W. Milne
Well-Defined Regions of Apolipoprotein B-100 Undergo Conformational Change During Its Intravascular Metabolism
Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1301 - 1308.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. van Antwerpen, M. La Belle, E. Navratilova, and R. M. Krauss
Structural heterogeneity of apoB-containing serum lipoproteins visualized using cryo-electron microscopy
J. Lipid Res., October 1, 1999; 40(10): 1827 - 1836.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Barbagallo, G. A. Levine, P. J. Blanche, B. Y. Ishida, and R. M. Krauss
Influence of ApoE Content on Receptor Binding of Large, Buoyant LDL in Subjects With Different LDL Subclass Phenotypes
Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 466 - 472.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Packard and J. Shepherd
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3542 - 3556.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ayaori, T. Ishikawa, H. Yoshida, M. Suzukawa, M. Nishiwaki, H. Shige, T. Ito, K. Nakajima, K. Higashi, A. Yonemura, et al.
Beneficial Effects of Alcohol Withdrawal on LDL Particle Size Distribution and Oxidative Susceptibility in Subjects With Alcohol-Induced Hypertriglyceridemia
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2540 - 2547.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
P. G. Scheffer, S. J. L. Bakker, R. J. Heine, and T. Teerlink
Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography
Clin. Chem., October 1, 1997; 43(10): 1904 - 1912.
[Abstract] [Full Text] [PDF]